Lawson Macartney
Chairman bei VIKING THERAPEUTICS, INC.
Vermögen: 4 Mio $ am 31.03.2024
Profil
Lawson Macartney is currently the Chairman at Viking Therapeutics, Inc. and the Senior Independent Non-Executive Director at Dechra Pharmaceuticals Plc.
He is also a Member of the Royal College of Veterinary Surgeons and a Member of the Supervisory Board at Netherlands Translational Research Center BV.
Dr. Macartney previously served as the President, Chief Executive Officer & Director at Ambrx, Inc. from 2013 to 2015.
He was also the Chief Executive Officer at Scout Bio, Inc. in 2017.
Additionally, he held positions such as Executive Director-Commercial Operations at Astra Merck, Inc. from 1996 to 1998, Vice President at Metabolic Research, Inc. from 2004 to 2007, Senior Vice President-Global Product Strategy at GSK Plc from 1999 to 2011, Vice President at Cardiovascular Group from 2004 to 2007, and Senior Vice President-Emerging Business Unit at Shire International GmbH (Switzerland) from 2011 to 2013.
Dr. Macartney obtained a doctorate degree from the University of Glasgow in 1982.
He also completed his undergraduate studies at the University of Glasgow School of Veterinary Medicine in 1979.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.03.2024 | 47 965 ( 0,04% ) | 4 Mio $ | 31.03.2024 |
Aktive Positionen von Lawson Macartney
| Unternehmen | Position | Beginn |
|---|---|---|
| VIKING THERAPEUTICS, INC. | Chairman | 01.05.2015 |
| DECHRA PHARMACEUTICALS | Director/Board Member | 01.12.2016 |
Royal College of Veterinary Surgeons
 Royal College of Veterinary Surgeons Miscellaneous Commercial ServicesCommercial Services The Royal College of Veterinary Surgeons is an organization that provides information on the outcomes of disciplinary hearings against veterinarians and registered veterinary nurses. The information includes announcements, charges, findings, reasons, decisions, judgments, and press releases. | Corporate Officer/Principal | - |
Netherlands Translational Research Center BV
 Netherlands Translational Research Center BV Medical/Nursing ServicesHealth Services Netherlands Translational Research Center BV develops small molecule drug leads and preclinical candidates for cancer, autoimmune and Parkinson diseases. Its product NFK GreenScreen plays an important role in immune modulation and neurodegenerative disease. The firm also offers Oncolines, OncolinesProfiler, SynergyFinder, ResidenceTimer and EntropySelect services. The company was founded by Guido J. R. Zaman and Rogier C. Buijsman in June 2011 and is headquartered in Oss, the Netherlands. | Director/Board Member | - |
Ehemalige bekannte Positionen von Lawson Macartney
| Unternehmen | Position | Ende |
|---|---|---|
Scout Bio, Inc.
 Scout Bio, Inc. Pharmaceuticals: MajorHealth Technology Scout Bio, Inc. operates as a biotechnology company that focuses on the innovation of pet medicine by delivering a pipeline of one-time therapeutics for major chronic pet health conditions. It also specializes in gene therapy, veterinary product development and biotechnology investment. The company was founded by James M. Wilson in 2016 and is headquartered in Philadelphia, PA. | Chief Executive Officer | 01.06.2017 |
| AMBRX INC | Chief Executive Officer | 01.06.2015 |
Shire International GmbH (Switzerland)
 Shire International GmbH (Switzerland) Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire International GmbH is a pharmaceutical company based in Zug, Switzerland. The Swiss company develops, manufactures, and markets pharmaceuticals. | Corporate Officer/Principal | 01.01.2013 |
| GSK PLC | Corporate Officer/Principal | 01.01.2011 |
Cardiovascular Group
 Cardiovascular Group Medical/Nursing ServicesHealth Services Cardiovascular Group provides cardiovascular services. | Corporate Officer/Principal | 01.01.2007 |
Ausbildung von Lawson Macartney
| University of Glasgow | Doctorate Degree |
| University of Glasgow School of Veterinary Medicine | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| GSK PLC | Health Technology |
| DECHRA PHARMACEUTICALS | Health Technology |
| VIKING THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 8 |
|---|---|
Metabolic Research, Inc.
 Metabolic Research, Inc. Pharmaceuticals: MajorHealth Technology Metabolic Research, Inc. is a biotechnology company that produces and markets proprietary nutraceuticals. The company is developing a new form of pharmaceutical-grade and non-synthetic pharmaceutical which is aimed to safely and effectively treat arthritis, heart disease and metabolic and inflammatory diseases. Metabolic Research was founded on October 7, 1996 and is headquartered in Las Vegas, NV. | Health Technology |
Royal College of Veterinary Surgeons
Royal College of Veterinary Surgeons Miscellaneous Commercial ServicesCommercial Services The Royal College of Veterinary Surgeons is an organization that provides information on the outcomes of disciplinary hearings against veterinarians and registered veterinary nurses. The information includes announcements, charges, findings, reasons, decisions, judgments, and press releases. | Commercial Services |
Astra Merck, Inc.
 Astra Merck, Inc. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, Astra Merck, Inc. is a private company that sells pharmaceutical products. The company is based in Orlando, FL. The company was founded by Myrtle S. Potter, Thomas A. McCourt. Astra Merck was acquired by Astra AB from Merck & Co., Inc. on July 12, 1998 for $4,400 million. | Health Technology |
Ambrx, Inc.
 Ambrx, Inc. Pharmaceuticals: MajorHealth Technology Ambrx, Inc. engages in discovering and developing of protein therapeutics. It offers non-native amino acids through expanded genetic code to both generate novel bio-therapeutics. The company was founded by Richard DiMarchi, Peter G. Schultz, and Troy E. Wilson on April 15, 2003 and is headquartered in La Jolla, CA. | Health Technology |
Cardiovascular Group
Cardiovascular Group Medical/Nursing ServicesHealth Services Cardiovascular Group provides cardiovascular services. | Health Services |
Shire International GmbH (Switzerland)
Shire International GmbH (Switzerland) Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire International GmbH is a pharmaceutical company based in Zug, Switzerland. The Swiss company develops, manufactures, and markets pharmaceuticals. | Health Technology |
Scout Bio, Inc.
Scout Bio, Inc. Pharmaceuticals: MajorHealth Technology Scout Bio, Inc. operates as a biotechnology company that focuses on the innovation of pet medicine by delivering a pipeline of one-time therapeutics for major chronic pet health conditions. It also specializes in gene therapy, veterinary product development and biotechnology investment. The company was founded by James M. Wilson in 2016 and is headquartered in Philadelphia, PA. | Health Technology |
Netherlands Translational Research Center BV
Netherlands Translational Research Center BV Medical/Nursing ServicesHealth Services Netherlands Translational Research Center BV develops small molecule drug leads and preclinical candidates for cancer, autoimmune and Parkinson diseases. Its product NFK GreenScreen plays an important role in immune modulation and neurodegenerative disease. The firm also offers Oncolines, OncolinesProfiler, SynergyFinder, ResidenceTimer and EntropySelect services. The company was founded by Guido J. R. Zaman and Rogier C. Buijsman in June 2011 and is headquartered in Oss, the Netherlands. | Health Services |
